Vancouver March 29, 2023 – Global Wellness Strategies Inc. (CSE: GWS) (Frankfurt: O3X4) (OTCQB: GWSFF) (“Global Wellness” or the “Company”) is pleased to announce that it has filed its annual financial statements for the fiscal year ended September 30, 2022, related management discussion and analysis (the ʺMD&Aʺ) and officer certificates on www.sedar.com, as required by the applicable Canadian Securities laws.
As previously announced the MCTO was issued by the BCSC on February 1, 2023. It prevents the Company’s President and Chief Financial Officer from trading in the Company’s securities but does not affect the ability of other shareholders, including the public, to trade in the securities of the Company.
The MCTO remains in effect until the Company files its interim financial documents for the period ended December 31, 2022 and the BCSC’s Executive Director has revoked the MCTO. The Company anticipates that it will file the Required Documents on or before April 3, 2023.
The Company confirms that since the date of the Default Announcement, other than as described above: (a) there has been no material change to the information set out in the Default Announcement that has not been generally disclosed; (b) there has been no failure by the Company in fulfilling its stated intentions with respect to satisfying the provisions of the alternative information guidelines set out in NP 12-203; (c) there has not been, nor is there anticipated to be, any specified default subsequent to the default which is the subject of the Default Announcement; and (d) there is no other material information concerning the affairs of the Company that has not been generally disclosed.
The Company confirms that it will continue to satisfy the provisions of the alternative information guidelines under NP 12-203 by issuing bi-weekly default status reports in the form of news releases for so long as it remains delayed in filing the Required Documents.
Global Wellness Strategies is a prospect generator that provides high growth companies with financial, operational, and management assistance in the fast growing market for wellness consumer products. The focus of the Company is on global wellness, psychedelics, mycology, hemp and CBD, healthcare-related target companies.
Or Contact Meris Kott CEO 604.484.0355 or email to [email protected]
Links to Financial Statements & MDMA Year Ended September 30/2022
Further information about the Company is available on www.SEDAR.com under the Company’s profile.
Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.